SCHEMBL21807152

SCHEMBL21807152

CS(=O)(=O)C1CCCN1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.37
PREP P48147 1/20 0.37
FAP Q12884 1/20 0.37
RIPK1 Q13546 1/20 0.36
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HCRTR2 O43614 9/20 0.34
ACE P12821 4/20 0.33
REN P00797 2/20 0.33
LMNA P02545 2/20 0.33
HSD17B10 Q99714 2/20 0.33
CYP2C19 P33261 1/20 0.33
F2 P00734 1/20 0.33
LTA4H P09960 1/20 0.33
MAPT P10636 1/20 0.33
PEPD P12955 1/20 0.33
ALOX15 P16050 1/20 0.33
PTGS1 P23219 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4893081 0.94 GAA (0.36) DPP4PREPFAPPOLBL3MBTL1
SCHEMBL20501449 0.88 RIPK1 (0.33) RIPK1KDM4EALDH1A1
SCHEMBL8509354 0.82 DPP4 (0.36) DPP4PREPFAPPOLBL3MBTL1
SCHEMBL27368424 0.82 POLB (0.35) DPP4PREPFAPRIPK1POLB
SCHEMBL4623155 0.80 POLB (0.34) DPP4PREPFAPRIPK1POLB
SCHEMBL2707073 0.80 CA2 (0.39) DPP4PREPFAPRIPK1POLB
SCHEMBL4623157 0.80 POLB (0.34) DPP4PREPFAPRIPK1POLB
SCHEMBL28059103 0.77 CA12 (0.37) DPP4PREPFAPPOLBALDH1A1
SCHEMBL26984528 0.76 RAB9A (0.38) L3MBTL1KDM4EACERENLMNA
SCHEMBL27094468 0.74 GAA (0.33) DPP4PREPFAPL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3853233-A1 TRI-SUBSTITUTED HETEROARYL DERIVATIVES AS SRC HOMOLOGY-2 PHOSPHATASE INHIBITORS Nikang Therapeutics, Inc. (US) 2021-07-28 EP disclosed
WO-2020061101-A1 TRI-SUBSTITUTED HETEROARYL DERIVATIVES AS SRC HOMOLOGY-2 PHOSPHATASE INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2020-03-26 WO disclosed